癌症登記軟體市場規模、佔有率和成長分析（按類型、部署模式、資料庫、功能、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，癌症登記軟體市場規模將達到 7,809 萬美元，到 2025 年將成長至 8,629 萬美元，到 2033 年將成長至 1.918 億美元，在預測期（2026-2033 年）內複合年成長率為 10.5%。

癌症登記軟體作為關鍵資料庫，負責組織、收集和維護患者資訊，用於評估治療效果。在降低醫療成本和提高醫療品質的驅動下，對有效癌症管理的需求日益成長，推動了軟體市場的顯著成長。癌症登記資料在市場監測中的應用日益廣泛，以及電子健康記錄 (EHR) 的普及，進一步促進了市場擴張。此外，簡化工作流程和減輕醫生工作量也使得整合軟體解決方案在醫療保健領域更具吸引力。政府對醫療管理的投入、對人口成長的關注以及監管舉措等關鍵因素，預計將加速癌症登記軟體的普及，因為該軟體具有許多營運優勢。

癌症登記軟體市場促進因素

癌症登記系統的發展主要得益於各國政府機構為降低癌症發生率所做的努力。在全球範圍內，各國政府機構正攜手合作，推動醫療衛生體系的數位化和一體化，包括建立電腦化的疾病登記系統。這一趨勢的驅動力源於對有效人群健康管理和醫療衛生資訊無縫交換日益成長的需求。這種整合不僅提高了資料收集的準確性，也促進了醫療服務提供者之間更緊密的合作，最終有助於改善病患預後，並提升醫療衛生系統的效率。

癌症登記軟體市場的限制因素

由於對資料隱私和安全的擔憂，癌症登記軟體市場面臨諸多阻礙。家庭詳細資訊通常與健康記錄關聯，一旦發生資料洩露，患者及其親屬的敏感資訊很可能會被洩露。對於許多已開發國家的政府而言，情況更加複雜，他們既要確保資訊獲取，又要保護個人隱私，這構成了一項艱鉅的挑戰。透明的資料共用需求與保護敏感健康資訊的必要性之間的矛盾，給該領域的相關人員帶來了巨大的挑戰。

癌症登記軟體市場趨勢

受腫瘤治療領域對高效數據管理需求的日益成長的推動，癌症登記軟體市場正經歷顯著成長。隨著全球醫療機構認知到詳細癌症數據對於監測、治療計劃和患者預後的重要性，先進的登記軟體系統應用顯著增加。醫療保健領域技術的日益融合，尤其是對即時分析、增強報告功能和全面患者追蹤的重視，也推動了這一趨勢。此外，監管壓力和對提高數據準確性的需求進一步促進了癌症登記軟體的應用，強化了其在臨床實踐和人群健康管理中的關鍵作用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL 分析
• 總體經濟指標

全球癌症登記軟體市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 獨立軟體
• 整合軟體

全球癌症登記軟體市場規模（按部署模式和複合年成長率分類）（2026-2033 年）

• 本地部署
• 基於雲端的

全球癌症登記軟體市場規模（按資料庫和複合年成長率分類）（2026-2033 年）

• 商業資料庫
• 公共資料庫

全球癌症登記軟體市場規模（按功能和複合年成長率分類）（2026-2033 年）

• 出於州和聯邦監管目的的癌症報告
• 患者照護管理
• 產品結果評估
• 醫學研究和臨床試驗

全球癌症登記軟體市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 政府機構和第三方管理機構（TPAS）
• 醫院和醫療機構
• 製藥、生技和醫療設備公司
• 私人保險公司
• 研究所

全球癌症登錄軟體市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• IBM Watson Health
• Oracle Corporation
• Siemens Healthineers
• Cerner Corporation
• Epic Systems Corporation
• MEDITECH
• Allscripts Healthcare Solutions
• McKesson Corporation
• Philips Healthcare
• GE Healthcare
• Inova Health System
• Varian Medical Systems
• Roche Diagnostics
• TomoTherapy Inc.
• Health Information Systems
• Elekta
• ONCO, Inc.
• Conduent, Inc.
• Ordinate Corporation
• Volpara Health Limited

結論與建議

Cancer Registry Software Market size was valued at USD 78.09 Million in 2024 and is poised to grow from USD 86.29 Million in 2025 to USD 191.8 Million by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).

Cancer registry software serves as a crucial database for organizing, collecting, and maintaining patient information to evaluate treatment outcomes. The market for such software is witnessing significant growth driven by the increasing need for effective cancer management, alongside a push to reduce healthcare costs while improving care quality. The rising utilization of cancer patient registry data for marketing surveillance, coupled with the broader adoption of electronic health records (EHRs), further propels market expansion. Additionally, streamlined workflows and reduced physician workloads enhance the appeal of integrated software solutions within healthcare. Key factors such as government investments in health management, population growth focus, and initiatives by regulatory agencies will likely accelerate the adoption of cancer registry software, driven by its numerous operational advantages.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cancer Registry Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cancer Registry Software Market Segments Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cancer Registry Software Market

The development of cancer registries is significantly supported by initiatives from various government agencies focused on decreasing cancer prevalence. There is a concerted effort by governmental organizations globally to digitize and unify healthcare frameworks, which includes the establishment of computerized disease registries. This movement is driven by the increasing need for effective population health management and the seamless exchange of health information. Such integration not only enhances the accuracy of data collection but also fosters better coordination among healthcare providers, ultimately contributing to improved patient outcomes and a more efficient healthcare system.

Restraints in the Cancer Registry Software Market

The Cancer Registry Software market faces significant restraint due to concerns surrounding data privacy and security. Family member details are often linked to health records, raising the stakes in the event of a data breach, as sensitive information about patients and their relatives could be exposed. This situation is further complicated for governments in numerous advanced economies, which struggle to navigate the complexities of ensuring information accessibility while simultaneously safeguarding individual privacy. The tension between the need for transparent data sharing and the imperative to protect confidential health information presents a formidable challenge for stakeholders in this sector.

Market Trends of the Cancer Registry Software Market

The Cancer Registry Software market is witnessing a significant upswing driven by the increasing need for effective data management in oncology care. As healthcare organizations globally recognize the importance of detailed cancer data for research, treatment planning, and patient outcomes, there is a marked rise in the adoption of advanced registry software systems. This trend is supported by the growing integration of technology in healthcare, emphasizing real-time analytics, enhanced reporting capabilities, and comprehensive patient tracking. Additionally, regulatory pressures and the need for improved data accuracy further propel cancer registry software's usage, reinforcing its critical role in both clinical settings and population health management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators

Global Cancer Registry Software Market Size by Type & CAGR (2026-2033)

• Market Overview
• Standalone Software
• Integrated Software

Global Cancer Registry Software Market Size by Deployment Model & CAGR (2026-2033)

• Market Overview
• On-premises
• Cloud-based

Global Cancer Registry Software Market Size by Database & CAGR (2026-2033)

• Market Overview
• Commercial Databases
• Public Databases

Global Cancer Registry Software Market Size by Functionality & CAGR (2026-2033)

• Market Overview
• Cancer Reporting to Meet State & Federal Regulations
• Patient Care Management
• Product Outcome Evaluation
• Medical Research and Clinical Studies

Global Cancer Registry Software Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Government Organizations & Third-party Administrators (TPAS)
• Hospitals & Medical Practices
• Pharmaceutical, Biotechnology, & Medical Device Companies
• Private Payers
• Research Centers

Global Cancer Registry Software Market Size & CAGR (2026-2033)

• North America, (Type, Deployment Model, Database, Functionality, End-User)
  • US
  • Canada
• Europe, (Type, Deployment Model, Database, Functionality, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Deployment Model, Database, Functionality, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Deployment Model, Database, Functionality, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Deployment Model, Database, Functionality, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Health System
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TomoTherapy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Information Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ONCO, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conduent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ordinate Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volpara Health Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation